Login Register Cart 0
Generic placeholder image

Current Indian Science

Editor-in-Chief

ISSN (Print): 2210-299X
ISSN (Online): 2210-3007

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Research Article

Pioglitazone Nanoparticle Deposited Biologically Active Substrate to Potentiate Antidiabetic Activity

Author(s): Talasila Eswara Gopalakrishna Murthy*, Sarihaddula Indira and Bodepudi Sudheer Chowdary

Volume 1, 2023

Published on: 23 October, 2023

Article ID: e2210299X233215 Pages: 6

DOI: 10.2174/012210299X233215230920151713

open_access

Open Access Journals Promotions 2
conference banner
Abstract

Background: Diabetes is one of the most escalating endocrine disorders around the global countries. Researchers are paying more attention towards herbal drugs for treating these chronic ailments. As per the statistics, the incidence of diabetes is increasing not only in adults but also in neonates. Herbal plants like Okra and Neem have been used in India since the ages to treat various kinds of ailments.

Methods: The methodology includes the preparation of granules from the okra gum and neem extract, which is compressed into tablets. The nanoparticle dispersion of Pioglitazone is prepared by using the 2% w/v polyvinyl pyrrolidone (PVP) and 1% sodium lauryl sulphate (SLS), which are then sprayed on the drug-free tablet substrate. This process enhances the area of the Pioglitazone particles and thereby increases the bioavailability of the drug. The spraying of the nanoparticles on the surface of the substrate reduces the aggregation of the particles, which is a drawback of nanoparticles.

Results: The results show that the release rate is increased 2.14 times compared with the pure drug by depositing Pioglitazone nanoparticles on a tablet substrate composed of the okra mucilage and alcoholic extract of Neem. It also shows that there is a remarkable reduction in the glucose levels in vivo when compared with the product formulated by employing the traditional wet granulation technique.

Conclusion: This study concluded that the addition of herbal antidiabetic molecules as excipients can improve the therapeutic effect significantly. Better antidiabetic activity may be obtained with the deposition of hydrophobic antidiabetic drugs on herbal antidiabetic components.

Keywords: Pioglitazone, Nanoparticles, Herbal excipients, Antidiabetic activity, Diabetes mellitus, Pharmacological approaches.

[1]
Upasani, SV; Nandedkar, RY; Upasani, MS; Ingle, PV; Patil, PH; Shah, VS Polyherbal formulation combination with metformin in patients with prediabetes. A randomized, controlled, observational study for clinical significance. Int. J. Pharma Bio Sci, 2017, 4(4), 8-15.
[2]
Thorpe, S.R.; Baynes, J.W. Role of the Maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging, 1996, 9(2), 69-77.
[http://dx.doi.org/10.2165/00002512-199609020-00001] [PMID: 8820792]
[3]
Elosta, A.; Ghous, T.; Ahmed, N. Natural products as anti-glycation agents: Possible therapeutic potential for diabetic complications. Curr. Diabetes Rev., 2012, 8(2), 92-108.
[http://dx.doi.org/10.2174/157339912799424528] [PMID: 22268395]
[4]
Zimmet, P.Z. Diabetes epidemiology as a tool to trigger diabetes research and care. Diabetologia, 1999, 42(5), 499-518.
[http://dx.doi.org/10.1007/s001250051188] [PMID: 10333041]
[5]
Galicia-Garcia, U.; Benito-Vicente, A.; Jebari, S.; Larrea-Sebal, A.; Siddiqi, H.; Uribe, K.B.; Ostolaza, H.; Martín, C. Pathophysiology of type 2 diabetes mellitus. Int. J. Mol. Sci., 2020, 21(17), 6275.
[http://dx.doi.org/10.3390/ijms21176275] [PMID: 32872570]
[6]
Samim, S.; Sood, S.; Singh, A.; Verma, A.; Kaur, A. Morphological characterization of okra [abelmoschus esculentus (L.) moench]. Int. J. Curr. Microbiol. Appl. Sci., 2018, 7(10), 2011-2019.
[http://dx.doi.org/10.20546/ijcmas.2018.710.232]
[7]
Sami, R.; Alshehry, G.; Ma, Y.; Abdelazez, A.; Benajiba, N.J. Evaluation of some specific components existences in okra (Abelmoschus esculentus L.(moench)) cultivated from different areas. J. Food Nutr. Res., 2019, 7(2), 155-161.
[http://dx.doi.org/10.12691/jfnr-7-2-8]
[8]
Woolfe, M.L.; Chaplin, M.F.; Otchere, G. Studies on the mucilages extracted from okra fruits (Hibiscus esculentus L.) and baobab leaves (Adansonia digitata L.). J. Sci. Food Agric., 1977, 28(6), 519-529.
[http://dx.doi.org/10.1002/jsfa.2740280609]
[9]
de Alvarenga Pinto Cotrim, M.; Mottin, A.C.; Ayres, E. Preparation and characterization of okra mucilage (Abelmoschus esculentus) edible films. Macromol. Symp., 2016, 367(1), 90-100.
[http://dx.doi.org/10.1002/masy.201600019]
[10]
Yadav, P.; Patel, P.; Das, P.; Deshmukh, N.; Pillai, S. Formulation and evaluation of pioglitazone HCl fast dissolving tablet using solid dispersion. Res. J. Pharm. Technol, 2018, 11(12), 5313-5318.
[http://dx.doi.org/10.5958/0974-360X.2018.00967.8]
[11]
Dantas, T.L.; Alonso Buriti, F.C.; Florentino, E.R. Okra (Abelmoschus esculentus L.) as a potential functional food source of mucilage and bioactive compounds with technological applications and health benefits. Plants, 2021, 10(8), 1683.
[http://dx.doi.org/10.3390/plants10081683] [PMID: 34451728]
[12]
Zhang, J.; Saltzman, M. Engineering biodegradable nanoparticles for drug and gene delivery. Chem. Eng. Prog., 2013, 109(3), 25-30.
[PMID: 25374435]
[13]
Dhar, P; Sarma, H; Sharma, HK Fixed dose oral dispersible tablet of bitter drug using okra mucilage: Formulation and evaluation. J. Drug Deliv. Ther, 2020, 10(15), 149-158.
[http://dx.doi.org/10.22270/jddt.v10i5.4393]
[14]
Javed, R.; Zia, M.; Naz, S.; Aisida, S.O.; Ain, N.; Ao, Q. Role of capping agents in the application of nanoparticles in biomedicine and environmental remediation: Recent trends and future prospects. J. Nanobiotechnology, 2020, 18(1), 172.
[http://dx.doi.org/10.1186/s12951-020-00704-4] [PMID: 33225973]
[15]
Hashim, N.; Abdullah, S.; Hassan, L.S.; Ghazali, S.R.; Jalil, R. A study of neem leaves: Identification of method and solvent in extraction. Mater. Today Proc., 2021, 42, 217-221.
[http://dx.doi.org/10.1016/j.matpr.2020.11.726]
[16]
Agrawal, R; Naveen, Y. Pharmaceutical processing–A review on wet granulation technology. Int. J. Pharm. Front., 2011, 1, 65-83.
[17]
Shaveta, S; Singh, J; Afzal, M; Kaur, R; Imam, SS; Alruwaili, NK; Alharbi, KS; Alotaibi, NH; Alshammari, MS; Kazmi, I; Yasir, M Development of solid lipid nanoparticle as carrier of pioglitazone for amplification of oral efficacy: Formulation design optimization, in-vitro characterization and in-vivo biological evaluation. J. Drug Deliv, 2020, 57, 101674.
[http://dx.doi.org/10.1016/j.jddst.2020.101674]
[18]
Todaro, B.; Moscardini, A.; Luin, S. Pioglitazone-loaded PLGA nanoparticles: Towards the most reliable synthesis method. Int. J. Mol. Sci., 2022, 23(5), 2522.
[http://dx.doi.org/10.3390/ijms23052522] [PMID: 35269665]
[19]
Sharma, A.K.; Kaushik, K. Formulation and evaluation of herbal antidiabetic tablet. J. Drug Deliv. Ther., 2011, 1(1), 65-67.
[http://dx.doi.org/10.22270/jddt.v1i1.24]
[20]
Dubey, P.; Mishra, S. A review on: Diabetes and okra (Abelmoschus esculentus). J. Med. Plants Stud., 2017, 5, 23-26.
[http://dx.doi.org/10.22270/jddt.v1i1.24]
[21]
Alam, M.A.; Al-Jenoobi, F.I.; Al-mohizea, A.M. Commercially bioavailable proprietary technologies and their marketed products. Drug Discov. Today, 2013, 18(19-20), 936-949.
[http://dx.doi.org/10.1016/j.drudis.2013.05.007] [PMID: 23707660]
[22]
United States Pharmacopeia and National Formulary (USP 43–NF 38). United States Pharmacopeial Convention, 2020.
[23]
Dholi, SK; Raparla, R; Mankala, SK; Nagappan, K In vivo antidiabetic evaluation of neem leaf extract in alloxan induced rats. J. Appl. Pharm. Sci, 2011, 30, 100-105.
[24]
Aleissa, MS; Mohammed, AZ; Alneghery, LM; Hasnain, MS; Almutairi, B; Ali, D; Alarifi, S; Alkahtani, S Comparative study of the anti-diabetic effect of mucilage and seed extract of Abelmoschus esculentus against streptozotocin-induced diabetes in rat model. 2022, 34(8), 102297.
[http://dx.doi.org/10.1016/j.jksus.2022.102297]
[25]
Stability testing of new drug substances and products Q1A(R2). International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use, https://database.ich.org/sites/default/files/Q1A%28R2%29%20Guideline.pdf

Rights & Permissions Print Cite
Article Metrics
4
1
Wayfinder Image
Open Access Journals Promotions
© 2024 Bentham Science Publishers | Privacy Policy